What is the main purpose of this 8-K filing?

This 8-K filing serves to announce a significant corporate name change from HCA Holdings, Inc. to HCA Healthcare, Inc., effective May 8, 2017. It also details a revised compensation structure for the company's Board of Directors and reports on the outcomes of the Annual Meeting of Stockholders.

Will the company's stock ticker symbol or CUSIP number change due to the name change?

No, the filing states that following the name change, the company's CUSIP number will remain the same, and its common stock will continue to trade on the New York Stock Exchange under the existing trading symbol 'HCA'.

How will the compensation for non-management directors change?

Non-management directors will now receive a combination of annual cash retainers based on their roles (e.g., board member, committee member, committee chair) and an annual equity award valued at $175,000. This equity award consists of restricted stock units that vest upon continued service for a year or until the next annual meeting. Directors are also subject to stock ownership guidelines.

Were there any significant shareholder proposals that passed or failed at the Annual Meeting?

At the Annual Meeting, all director nominees were elected, and Ernst & Young LLP was ratified as the auditor. However, an amendment to the company's certificate of incorporation to allow certain stockholders to request special meetings did not receive the required supermajority vote and was not approved. A separate stockholder proposal regarding special shareowner meetings also failed to pass.

HCA 8-K: Leadership Changes, Shareholder Matters & More

Summary

This 8-K filing for HCA Healthcare, Inc. (formerly HCA Holdings, Inc.) primarily details changes related to corporate governance and identity, including an upcoming name change and adjustments to the Board of Directors' compensation structure. Effective May 8, 2017, the company will officially be known as HCA Healthcare, Inc., with corresponding amendments to its Certificate of Incorporation and Bylaws. This name change, while significant for branding, does not impact the stock's trading symbol or CUSIP number. Additionally, the filing outlines a revised compensation program for non-management directors, which includes a mix of annual cash retainers for board service and committee roles, as well as an annual equity award valued at $175,000. The company is also implementing stock ownership guidelines for directors, requiring them to acquire company stock valued at five times their annual cash retainer within three years. These changes are designed to better align director interests with those of shareholders.

Key Highlights

1HCA Holdings, Inc. will change its name to HCA Healthcare, Inc. effective May 8, 2017.
2The company's stock will continue trading under the 'HCA' symbol on the NYSE with the same CUSIP number post-name change.
3A revised compensation program for non-management directors was approved, including annual cash retainers and equity awards.
4Non-management directors will receive an annual board equity award valued at $175,000, vesting on the first anniversary of the grant date or the next annual meeting.
5New stock ownership guidelines require non-management directors to acquire company stock valued at five times their annual cash retainer within three years.
6All 11 director nominees were elected at the Annual Meeting of Stockholders held on April 27, 2017.
7Ernst & Young LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2017.

HCA Healthcare, Inc. 8-K Report, Executive Changes (Apr 28, 2017)

Summary

Key Highlights

Frequently Asked Questions